The world's scientific and social network for malaria professionals
Subscribe to free Newsletter | 10659 malaria professionals are enjoying the free benefits of MalariaWorld today

p. falciparum

Diversity and Multiplicity of P. falciparum infections among asymptomatic school children in Mbita, Western Kenya

April 6, 2020 - 16:08 -- Open Access
Author(s): 
Touray AO, Mobegi VA, Wamunyokoli F, Herren JK
Reference: 
Sci Rep. 2020 Apr 3;10(1):5924

Multiplicity of infection (MOI) and genetic diversity of P. falciparum infections are important surrogate indicators for assessing malaria transmission intensity in different regions of endemicity. Determination of MOI and diversity of P. falciparum among asymptomatic carriers will enhance our understanding of parasite biology and transmission to mosquito vectors.

A randomized clinical trial to compare P. falciparum gametocytaemia and infectivity following blood-stage or mosquito bite induced controlled malaria infection

April 6, 2020 - 15:41 -- Open Access
Author(s): 
Alkema M, Reuling IJ, Bousema T, et al.
Reference: 
J Infect Dis. 2020 Apr 2. pii: jiaa157

For malaria elimination efforts it is important to better understand parasite transmission to mosquitoes and develop models for early-clinical evaluation of transmission-blocking interventions.

Blood group and size dependent stability of P. falciparum infected red blood cell aggregates in capillaries

March 25, 2020 - 14:57 -- Open Access
Author(s): 
Jötten AM, Moll K, Wahlgren M, Wixforth A, Westerhausen C
Reference: 
Biomicrofluidics, Volume 14, Issue 2

For Plasmodium falciparum related malaria (B50), one of the outstanding host factors for the development of severe disease is the ABO blood group of malaria patients, where blood group O reduces the probability of severe disease as compared to individuals of groups A, B, or AB.

NOT Open Access | Nano-Focused Scanning X-ray Fluorescence Microscopy Reveals an Effect of Hemoglobin S and C on Biochemical Activities in P. falciparum-Infected Erythrocytes

March 24, 2020 - 12:29 -- NOT Open Access
Author(s): 
Fröhlich B, Yang Y, Thoma J, Czajor J, Lansche C, Sanchez C, Lanzer M, Cloetens P, Tanaka M
Reference: 
Anal Chem. 2020 Mar 23

Ample evidence suggesting that carriers of hemoglobin S and C are protected from life-threatening malaria, but little is known about the underlying biochemical mechanisms at the single cell level. Using nano-focused scanning X-ray fluorescence microscopy, we quantify the spatial distribution of individual elements in subcellular compartments, including Fe, S, P, Zn, and Cu, in Plasmodium falciparum-infected erythrocytes carrying the wild type or variant hemoglobins.

Not Open Access | The Antimalarial Natural Product Salinipostin A Identifies Essential α/β Serine Hydrolases Involved in Lipid Metabolism in P. falciparum Parasites

February 24, 2020 - 13:40 -- NOT Open Access
Author(s): 
Yoo E, Schulze CJ, Stokes BH, Onguka O, Yeo T, Mok S, Gnädig NF, Zhou Y, Kurita K, Foe IT, Terrell SM, Boucher MJ, Cieplak P, Kumpornsin K, Lee MCS, Linington RG, Long JZ, Uhlemann AC, Weerapana E, Fidock DA, Bogyo M
Reference: 
Cell Chem Biol. 2020 Feb 20;27(2):143-157.e5

Salinipostin A (Sal A) is a potent antiplasmodial marine natural product with an undefined mechanism of action. Using a Sal A-derived activity-based probe, we identify its targets in the Plasmodium falciparum parasite. All of the identified proteins contain α/β serine hydrolase domains and several are essential for parasite growth. One of the essential targets displays a high degree of homology to human monoacylglycerol lipase (MAGL) and is able to process lipid esters including a MAGL acylglyceride substrate.

Preclinical Antimalarial Combination Studies: The Case of M5717, a P. falciparum Elongation Factor 2 Inhibitor and Pyronaridine, a Hemozoin Formation Inhibitor

February 17, 2020 - 14:33 -- Open Access
Author(s): 
Rottmann M, Jonat B, Spangenberg T, et al.
Reference: 
Antimicrob Agents Chemother. 2020 Feb 10, pii: AAC.02181-19.

Antimalarial drug resistance in the Plasmodium falciparum parasite poses a constant challenge for drug development. To mitigate this risk, new antimalarial medicines should be developed as fixed-dose combinations. Assessing the pharmacodynamic interactions of potential antimalarial drug combination partners during early phases of development is essential in developing the targeted parasitological and clinical profile of the final drug product.

NOT Open Access | Mannosylated liposomes formulated with whole parasite P. falciparum blood-stage antigens are highly immunogenic in mice

January 15, 2020 - 09:12 -- NOT Open Access
Author(s): 
Ssemaganda A, Giddam AK, Low LM, Liu XQ, Ho MF, Zaman M, Hussein WM, Skwarczynski M, Toth I, Stanisic DI, Good MF
Reference: 
Vaccine, 2019 Dec 19. pii: S0264-410X(19)31617-2

The development of a blood-stage malaria vaccine has largely focused on the subunit approach. However, the limited success of this strategy, mainly due to antigenic polymorphism and the failure to maintain potent parasite-specific immune responses, indicates that other approaches must be considered. Whole parasite (WP) vaccines offer many advantages over sub-units; they represent every antigen on the organism, thus limiting the effects of antigenic polymorphism, and similarly they compensate for individual Immune-Response (Ir) gene-regulated non-responsiveness to any particular antigen. From a development perspective, they negate the need to identify and compare the relative efficacies of individual candidate antigens. WP vaccines induce protective immunity that is largely cell-mediated.

P. falciparum gametocyte density and infectivity in peripheral blood and skin tissue of naturally infected parasite carriers in Burkina Faso

January 15, 2020 - 09:03 -- Open Access
Author(s): 
Meibalan E, Barry A, Gibbins MP, Awandu S, Meerstein-Kessel L, Achcar F, Bopp S, Moxon C, Diarra A, Debe S, Ouédraogo N, Barry-Some I, Badoum E, Fagnima T, Lanke K, Gonçalves BP, Bradley J, Wirth D, Drakeley C, Guelbeogo WM, Tiono AB, Marti M, Bousema T
Reference: 
The Journal of Infectious Diseases, jiz680

Plasmodium falciparum transmission depends on mature gametocytes that can be ingested by mosquitoes taking a bloodmeal on human skin. Although gametocyte skin sequestration has long been hypothesized as important contributor to efficient malaria transmission, this has never been formally tested.

NOT Open Access | In-silico profiling and structural insights into the impact of nSNPs in the P. falciparum acetyl-CoA transporter gene to understand the mechanism of drug resistance in malaria

January 14, 2020 - 16:24 -- NOT Open Access
Author(s): 
Sardar R, Katyal N, Ahamad S, Jade DD, Ali S, Gupta D
Reference: 
Journal of Biomolecular Structure and Dynamics, 2020 Jan 6:1-23

The continuous emergence of resistance to the available drugs poses major constraints in the development of effective therapeutics against Malaria. The Malaria drug resistance has been attributed to be the manifestation of numerous factors. For example, mutations in the parasite transporter protein acetyl-CoA transporter (Pfact) can remarkably affect its uptake affinity for a drug molecule against malaria, and hence enhance its susceptibility to resistance.

Molecular monitoring of the diversity of human pathogenic malaria species in blood donations on Bioko Island, Equatorial Guinea

January 15, 2019 - 15:30 -- Open Access
Author(s): 
Tobias Schindler, Tamy Robaina, Claudia Daubenberger, et al.
Reference: 
Malaria Journal 2019 18:9, 15 January 2019

This study confirms that in malaria endemic settings, sub-patent malaria infections among blood donors are prevalent.

Medical Condition: 

Pages

Subscribe to RSS - p. falciparum